David. Blumberg

David Blumberg has significant experience in the pharmaceutical and life sciences sectors, currently serving as a Member of the Board of Directors for IAVI since January 2019 and holding the position of VP Global Commercial Compliance at Teva Pharmaceuticals since December 2015. Prior to these roles, David was a Retired Partner at KPMG Advisory, where David. led the Pharmaceutical/Life Sciences sector until July 2008. David also served on the Board of Directors for Aeras TB Vaccines from August 2015 to January 2019 and held various leadership roles at KPMG and I-many, Inc. David's early career included positions at Accenture and Astra Merck. David earned an MBA in Management/Finance from The Wharton School and a Bachelor's Degree in Mechanical Engineering from The Ohio State University.